Terms: = Ovarian cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD
208 results:
1. CRISPR du-HITI an attractive approach to targeting Long Noncoding RNA HCP5 as inhibitory factor for proliferation of ovarian cancer cell.
Moradi Z; Kazemi M; Jamshidi-Khalifelou R; Bahramnia V; Esfandmaz F; Rahnavard R; Moradgholi B; Piri-Gharaghie T
Funct Integr Genomics; 2024 Mar; 24(2):61. PubMed ID: 38507114
[TBL] [Abstract] [Full Text] [Related]
2. Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway.
Wang H; Xu YH; Guo Y
J Ovarian Res; 2024 Feb; 17(1):50. PubMed ID: 38395907
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptomic Analysis of the Aged Nulliparous Mouse Ovary Suggests a Stress State That Promotes Pro-Inflammatory Lipid Signaling and Epithelial Cell Enrichment.
Chacón C; Mounieres C; Ampuero S; Urzúa U
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203684
[TBL] [Abstract] [Full Text] [Related]
4. [News in breast oncology genetics for female and male population].
Taris N; Luporsi E; Osada M; Thiblet M; Mathelin C
Gynecol Obstet Fertil Senol; 2024 Mar; 52(3):149-157. PubMed ID: 38190969
[TBL] [Abstract] [Full Text] [Related]
5. CXCR4-directed PET/CT with [
Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
[TBL] [Abstract] [Full Text] [Related]
6. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, ovarian, and Pancreatic, Version 2.2024.
Daly MB; Pal T; Maxwell KN; Churpek J; Kohlmann W; AlHilli Z; Arun B; Buys SS; Cheng H; Domchek SM; Friedman S; Giri V; Goggins M; Hagemann A; Hendrix A; Hutton ML; Karlan BY; Kassem N; Khan S; Khoury K; Kurian AW; Laronga C; Mak JS; Mansour J; McDonnell K; Menendez CS; Merajver SD; Norquist BS; Offit K; Rash D; Reiser G; Senter-Jamieson L; Shannon KM; Visvanathan K; Welborn J; Wick MJ; Wood M; Yurgelun MB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2023 Oct; 21(10):1000-1010. PubMed ID: 37856201
[TBL] [Abstract] [Full Text] [Related]
7. [
Guo X; Chen L; Lü Q; DU R; Luo Q; Zhang Y; Bian H; Han L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1315-1321. PubMed ID: 37712267
[TBL] [Abstract] [Full Text] [Related]
8. Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC).
Fernández Madrigal L; Rodríguez Garcés MY; Jiménez Ruiz FJ
Curr Probl Cancer; 2023 Dec; 47(6):101008. PubMed ID: 37704491
[TBL] [Abstract] [Full Text] [Related]
9. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
[TBL] [Abstract] [Full Text] [Related]
10. Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and ovarian cancer.
Desai NV; Barrows ED; Nielsen SM; Hatchell KE; Anderson MJ; Haverfield EV; Herrera B; Esplin ED; Lucassen A; Tung NM; Isaacs C
JCO Precis Oncol; 2023 Aug; 7():e2200695. PubMed ID: 37535880
[TBL] [Abstract] [Full Text] [Related]
11. Clinical benefit of switching from paclitaxel to docetaxel or vice versa in cutaneous angiosarcoma patients resistant to first taxane chemotherapy.
Yonekura S; Endo Y; Fujii H; Ishikawa M; Egawa G; Kabashima K
J Dermatol; 2023 Nov; 50(11):1493-1496. PubMed ID: 37400887
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital.
Oliveira MJ; Costa S; Magalhães A; Garrido L; Peleteiro B; Fougo JL; Castedo S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11145-11156. PubMed ID: 37347260
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Value of Lymph Node Parameters in Elderly Patients With Stage III Serous ovarian cancer Based on Competing Risk Model.
Sun X; Peng Y; Chen J; Lei J; Liu W; Li Z
Am J Clin Oncol; 2023 Aug; 46(8):337-345. PubMed ID: 37146258
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of pathogenic variation in gynecologic cancer genes in a national cohort.
Kotnik U; Maver A; Peterlin B; Lovrecic L
Sci Rep; 2023 Mar; 13(1):5307. PubMed ID: 37002323
[TBL] [Abstract] [Full Text] [Related]
15. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
16. Prevalence of Pathogenic Germline Mutations in 13 Hereditary cancer-Related Genes in Breast cancer Patients in Narathiwat Province, Thailand.
Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S
Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301
[TBL] [Abstract] [Full Text] [Related]
17. Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Luen SJ; Viale G; Nik-Zainal S; Savas P; Kammler R; Dell'Orto P; Biasi O; Degasperi A; Brown LC; Láng I; MacGrogan G; Tondini C; Bellet M; Villa F; Bernardo A; Ciruelos E; Karlsson P; Neven P; Climent M; Müller B; Jochum W; Bonnefoi H; Martino S; Davidson NE; Geyer C; Chia SK; Ingle JN; Coleman R; Solbach C; Thürlimann B; Colleoni M; Coates AS; Goldhirsch A; Fleming GF; Francis PA; Speed TP; Regan MM; Loi S
Ann Oncol; 2023 Apr; 34(4):397-409. PubMed ID: 36709040
[TBL] [Abstract] [Full Text] [Related]
18. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
[TBL] [Abstract] [Full Text] [Related]
19. Associations of Dietary Intakes with Gynecological cancers: Findings from a Cross-Sectional Study.
Zhu G; Li Z; Tang L; Shen M; Zhou Z; Wei Y; Zhao Y; Bai S; Song L
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501056
[TBL] [Abstract] [Full Text] [Related]
20. Beta-Caryophyllene Enhances the Anti-Tumor Activity of Cisplatin in Lung cancer Cell Lines through Regulating Cell Cycle and Apoptosis Signaling Molecules.
Ahmed EA; Abu Zahra H; Ammar RB; Mohamed ME; Ibrahim HM
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500446
[TBL] [Abstract] [Full Text] [Related]
[Next]
